We are live on ! Find out more
CARM

Carisma Therapeutics
CARM

Delisted

CARM was delisted on the 10th of October, 2025.

Back to rankings

32 hedge funds and large institutions have $185M invested in Carisma Therapeutics in 2014 Q1 according to their latest regulatory filings, with 32 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
+32
Holders Change %
–
% of All Funds
0.92%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
32
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TRV
Third Rock Ventures
Massachusetts
+$72.5M
2
FV2GP
Flagship Ventures 2007 General Partner
Massachusetts
+$28.6M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$24.2M
4
Franklin Resources
Franklin Resources
California
+$14M
5
BC
Broadfin Capital
New York
+$12.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
TRV
1
Third Rock Ventures
Massachusetts
$78.6M +$72.5M +242,080 New
FV2GP
2
Flagship Ventures 2007 General Partner
Massachusetts
$31M +$28.6M +95,350 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$26.2M +$24.2M +80,736 New
Franklin Resources
4
Franklin Resources
California
$15.2M +$14M +46,905 New
BC
5
Broadfin Capital
New York
$14M +$12.9M +43,097 New
JP Morgan Chase
6
JP Morgan Chase
New York
$5.11M +$4.72M +15,744 New
BFA
7
BlackRock Fund Advisors
California
$1.8M +$1.66M +5,559 New
TG
8
TCW Group
California
$1.71M +$1.58M +5,278 New
Principal Financial Group
9
Principal Financial Group
Iowa
$1.55M +$1.43M +4,765 New
BA
10
BlackRock Advisors
Delaware
$1.47M +$1.36M +4,532 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$1.41M +$1.3M +4,344 New
SONJCPFA
12
State of New Jersey Common Pension Fund A
New Jersey
$1.22M +$1.12M +3,750 New
SAM
13
Sectoral Asset Management
Quebec, Canada
$812K +$749K +2,500 New
BIT
14
BlackRock Institutional Trust
California
$659K +$608K +2,031 New
Northern Trust
15
Northern Trust
Illinois
$612K +$565K +1,885 New
BG
16
BlackRock Group
United Kingdom
$597K +$551K +1,840 New
State Street
17
State Street
Massachusetts
$469K +$432K +1,444 New
NSEDCP
18
NJ State Employees Deferred Compensation Plan
New Jersey
$406K +$374K +1,250 New
SCA
19
SAC Capital Advisors
Connecticut
$393K +$363K +1,211 New
Geode Capital Management
20
Geode Capital Management
Massachusetts
$350K +$324K +1,081 New
NFA
21
Nationwide Fund Advisors
Ohio
$313K +$289K +965 New
BlackRock
22
BlackRock
New York
$304K +$280K +935 New
TCIM
23
TIAA CREF Investment Management
New York
$242K +$223K +746 New
Goldman Sachs
24
Goldman Sachs
New York
$175K +$161K +539 New
Bank of New York Mellon
25
Bank of New York Mellon
New York
$167K +$154K +514 New
1
2

CARM Hedge Fund Activity: Q1 2014 in Review

32 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Carisma Therapeutics (CARM) for Q1 2014, worth a combined $185M.

Buyers outnumbered sellers: 32 funds opened new CARM positions and 0 closed out — a net gain of 32 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Third Rock Ventures, opening a new position worth an estimated $72.5M.

  • 32 institutional investors held Carisma Therapeutics (CARM) as of Q1 2014, up from 0 in Q4 2013.
  • Funds reported $185M of Carisma Therapeutics stock for Q1 2014.
  • 32 funds opened new Carisma Therapeutics positions in Q1 2014 and 0 closed out, a net change of +32 holders.
  • The largest Carisma Therapeutics buyer in Q1 2014 was Third Rock Ventures, an estimated $72.5M added.

Based on aggregated 13F filings for Q1 2014.